Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Mediators of Inflammation|February 28, 2018
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional StudyGian Luca Erre, Matteo Piga, Anna Laura Fedele, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
RMD Open|July 25, 2020
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI)Matteo Piga, Alberto Floris, Gerard Espinosa, et al.
Rheumatology (Oxford, England)|December 17, 2019
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohortMatteo Piga, Alberto Floris, Gian Domenico Sebastiani, et al.
Rheumatology (Oxford, England)|November 15, 2011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsMarcello Govoni, Stefano Bombardieri, Alessandra Bortoluzzi, et al.
Arthritis and Rheumatism|December 31, 2005
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysisFotini B Karassa, Antonella Afeltra, Ales Ambrozic, et al.
Medicine|October 8, 2003
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patientsRicard Cervera, Munther A Khamashta, Josep Font, et al.
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Pageof 10